Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
Authors:
- 1 June 1999
- journal article
- clinical trial
- Published by Springer Nature in Nature Medicine
- Vol. 5 (6) , 651-655
Abstract
The size of the pool of resting CD4+ T cells containing replication-competent HIV in the blood of patients receiving intermittent interleukin (IL)-2 plus highly active anti-retroviral therapy (HAART) was significantly lower than that of patients receiving HAART alone. Virus could not be isolated from the peripheral blood CD4+ T cells in three patients receiving IL-2 plus HAART, despite the fact that large numbers of resting CD4+ T cells were cultured. Lymph node biopsies were done in two of these three patients and virus could not be isolated. These results indicate that the intermittent administration of IL-2 with continuous HAART may lead to a substantial reduction in the pool of resting CD4+ T cells that contain replication-competent HIV.Keywords
This publication has 29 references indexed in Scilit:
- Outpatient Continuous Intravenous Interleukin‐2 or Subcutaneous, Polyethylene Glycol‐Modified Interleukin‐2 in Human Immunodeficiency Virus‐Infected Patients: A Randomized, Controlled, Multicenter StudyThe Journal of Infectious Diseases, 1998
- Comparison between subcutaneous and intravenous interleukin‐2 treatment in HIV diseaseJournal of Internal Medicine, 1998
- A National Tissue Bank to Track HIV Eradication and Immune ReconstitutionScience, 1998
- Exploring How to Get at--and Eradicate--Hidden HIVScience, 1998
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997
- Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1996
- Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary StudyNew England Journal of Medicine, 1995
- Antigen-independent activation of naive and memory resting T cells by a cytokine combination.Journal of Experimental Medicine, 1994
- Rapid Cytokine Release in Cancer Patients Treated with Interleukin-2Journal of Immunotherapy, 1992
- Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatantsEuropean Journal of Cancer, 1992